Table 1 Baseline characteristics of participants at trial entry
Variable | Group | P value | ||
|---|---|---|---|---|
Baclofen (n = 15) | Placebo (n = 15) | |||
Age | Mean (SD) | 60.38 (19.61) | 58.64 (18.57) | 0.78 |
Gender | ||||
Male | 8 (53.33%) | 9 (60.00%) | 0.71 | |
Female | 7 (47.67%) | 6 (40.00%) | 0.71 | |
Married | 15 (100%) | 14 (93.33%) | 0.47 | |
Ethnicity | ||||
Han Chinese | 14 (93.33%) | 13 (86.66%) | 0.55 | |
Other | 0 (0.0%) | 1 (6.67%) | 0.49 | |
Not recorded | 1 (6.67%) | 1 (6.67%) | 1.00 | |
Employment | ||||
Employed | 2 (13.33%) | 1 (6.67%) | 0.55 | |
Unemployed | 1 (6.67%) | 1 (6.67%) | 1.00 | |
Retired | 12 (80.00%) | 13 (86.66%) | 0.63 | |
Education | ||||
Completed high school | 12 (80.00%) | 13 (86.66%) | 0.63 | |
Completed tertiary education | 3 (20.00%) | 2 (13.34%) | 0.63 | |
Duration of hiccups (hours) | Mean (SD) | 59.24 (9.65) | 61.32 (10.34) | 0.51 |
Stroke | ||||
Ischemic | 10 (66.67%) | 9 (60.00%) | 0.71 | |
Hemorrhagic | 5 (33.33%) | 6 (40.00%) | 0.71 | |
Duration of stroke (months) | Mean (SD) | |||
Ischemia | 3.71 (1.28) | 3.65 (1.32) | 0.90 | |
Hemorrhage | 3.83 (1.35) | 3.87 (1.39) | 0.94 | |
Severity of stroke | Mean (SD) | |||
FMA | 49.56 (21.67) | 51.21 (23.11) | 0.84 | |
MBI | 50.97 (24.15) | 52.24 (23.53) | 0.88 | |
NDS | 15.12 (5.89) | 13.96 (5.77) | 0.59 | |